Novavax begins mid-stage study of Covid-19 vaccine in South Africa | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 30, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 30, 2025
Novavax begins mid-stage study of Covid-19 vaccine in South Africa

Coronavirus chronicle

Reuters
17 August, 2020, 10:35 pm
Last modified: 17 August, 2020, 10:37 pm

Related News

  • South Africa town leader 'sad' about Trump's misuse of white crosses video
  • Trump confronts South Africa's Ramaphosa with false claims of white genocide
  • First white South Africans arrive in US as Trump claims they face discrimination
  • First white South Africans board plane for US under Trump refugee plan
  • First white South Africans to arrive under US refugee plan as soon as next week

Novavax begins mid-stage study of Covid-19 vaccine in South Africa

South Africa is the fifth worst affected country with 583,653 coronavirus cases and 11,677 deaths

Reuters
17 August, 2020, 10:35 pm
Last modified: 17 August, 2020, 10:37 pm
A member of the South African National Defense Forces keeps watch as homeless men stand in a queue during the first day of a nationwide lockdown for 21 days to try to contain the coronavirus disease (Covid-19) outbreak, in Johannesburg, South Africa, March 27, 2020. REUTERS/Siphiwe Sibeko
A member of the South African National Defense Forces keeps watch as homeless men stand in a queue during the first day of a nationwide lockdown for 21 days to try to contain the coronavirus disease (Covid-19) outbreak, in Johannesburg, South Africa, March 27, 2020. REUTERS/Siphiwe Sibeko

US drug developer Novavax Inc said on Monday it started a mid-stage study of its experimental Covid-19 vaccine in South Africa, as the country experiences a surge in coronavirus cases.

South Africa is the fifth worst affected country with 583,653 coronavirus cases and 11,677 deaths, according to a Reuters tally.

"Because South Africa is experiencing a winter surge of Covid-19 disease, this important Phase 2b clinical trial has the potential to provide an early indication of efficacy," Novavax research chief Gregory Glenn said.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

The trial of Novavax's NVX-CoV2373, backed by a $15 million grant from Bill & Melinda Gates Foundation, was being conducted in two separate groups, one comprising 2,665 healthy volunteers and the other, 240 HIV-positive adults.

Novavax expects its vaccine, once approved, would be supplied to South Africa through a deal signed earlier this year with the Serum Institute of India to develop and commercialize NVX-CoV2373.

The vaccine candidate is one of nearly 30 globally being tested in human clinical trials.

Early-stage data from a small clinical trial of the vaccine has shown that it produced high levels of virus-fighting antibodies, and the company aims to begin larger studies to obtain regulatory approvals as early as December.

Novavax intends to begin Phase 2 of the small clinical trial in the United States and Australia in the near future and said it would include about 1,500 candidates. It also aims to begin Phase III as soon as late September.

The US government in July awarded Novavax $1.6 billion to cover testing its potential coronavirus vaccine in the United States and manufacturing with the aim of delivering a 100 million doses by January.

Novavax / covid-19 vaccine / south africa

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Saleh Uddin Ahmed. Sketch: TBS
    Govt working to fulfil 3 responsibilities - election, some reforms, outlining sectoral reform: Salehuddin
  • Children and a rickshaw-puller pedal through the rain-soaked streets of Dhaka on 16 April 2025. Photo: Photo: Rajib Dhar/TBS
    Noakhali witnesses 285mm rainfall in 24 hrs, highest in the country; Dhaka 196mm
  • BNP Standing Committee Member Mirza Abbas and other senior party leaders pay tributes at the grave of BNP founder and former president Ziaur Rahman at Chandrima Udyan in the capital’s Sher-e-Bangla Nagar on 30 May 2025. Photo: BNP Media Cell
    Only Yunus doesn't want polls, says Mirza Abbas slamming CA for 'slandering BNP'

MOST VIEWED

  • Photo: Courtesy
    New notes featuring historic, archaeological structures of Bangladesh to be circulated from 1 June
  • Two Memoranda of Understanding were signed at the seminar titled “Bangladesh Seminar on Human Resources,” in Tokyo on 29 May 2025. Photo: CA Press Wing
    Japan to recruit 100,000 Bangladeshi workers over next 5 years
  • Representational Photo: Collected
    Country's all jewellery shops to remain indefinitely closed in protest of VP Reponul's arrest: Bajus
  • BAT Bangladesh has to vacate Mohakhali HQ as SC rejects lease appeal
    BAT Bangladesh has to vacate Mohakhali HQ as SC rejects lease appeal
  • Illustration: TBS
    Bangladesh repays $3.5b foreign debt in 10 months of FY25
  • Khondoker Rashed Maqsood. File Photo: Collected
    Investors urge removal of BSEC chairman in meeting with CA’s special assistant, submit list of demands

Related News

  • South Africa town leader 'sad' about Trump's misuse of white crosses video
  • Trump confronts South Africa's Ramaphosa with false claims of white genocide
  • First white South Africans arrive in US as Trump claims they face discrimination
  • First white South Africans board plane for US under Trump refugee plan
  • First white South Africans to arrive under US refugee plan as soon as next week

Features

Photos: Courtesy

Behind the looks: Bangladeshi designers shaping celebrity fashion

2h | Mode
Photo collage of the sailors and their catch. Photos: Shahid Sarkar

Between sky and sea: The thrilling life afloat on a fishing ship

6h | Features
For hundreds of small fishermen living near this delicate area, sustainable fishing is a necessity for their survival. Photo: Syed Zakir Hossain

World Ocean Day: Bangladesh’s ‘Silent Island’ provides a fisheries model for the future

23h | The Big Picture
The university will be OK. But will the US? Photo: Bloomberg

A weaker Harvard is a weaker America

23h | Panorama

More Videos from TBS

Six MoUs signed during Chief Advisor's visit to Japan

Six MoUs signed during Chief Advisor's visit to Japan

1h | TBS Today
Record migrant deaths in 2024

Record migrant deaths in 2024

20h | Podcast
Govt likely to trim subsidies in new budget

Govt likely to trim subsidies in new budget

4h | TBS Insight
News of The Day, 29 MAY 2025

News of The Day, 29 MAY 2025

21h | TBS News of the day
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net